Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about CureMetrix match what happens in practice?
Still openReal-world behaviour on the accuracy quality.
Public evidence
Reduction of False-Positive Markings on Mammograms: a Retrospective Comparison Study Using an Artificial Intelligence-Based CAD
SignalHunt:validation:CureMetrix
Public evidence
Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality
SignalHunt:validation:CureMetrix
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
Nobody has answered these yet. Your experience can help us understand what is happening.
Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
Settled elsewhere. Context for reading the above, not something practice can confirm.
Tool intelligence
HealthAratus currently understands CureMetrix through regulatory records and company records.
HealthAratus is beginning to understand CureMetrix. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
The material the questions above were built from, with its attribution.
CureMetrix provides AI software designed to analyze mammography images. The technology identifies and marks breast arterial calcifications for radiologist review.According to CureMetrix
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The software identifies and marks breast arterial calcifications on screening mammograms.
According to CureMetrix
Does this change your workflow?
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported outcome
Reduction of False-Positive Markings on Mammograms: a Retrospective Comparison Study Using an Artificial Intelligence-Based CAD
Reported publicly
Are you seeing this result?
Reported outcome
Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality
Reported publicly
Are you seeing this result?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
• Product Overview: CureMetrix offers AI-powered solutions for mammography, focusing on the detection and localization of Breast Arterial Calcifications (BAC) in screening mammograms. • Technical Functionality: The cmAngio® software analyzes both full-field digital mammography (FFDM) and digital breast…
Vendor & external product information, not independently verified by HealthAratus
Deployed in mixed settings, US
Regulatory: FDA 510(k) cleared
AI-driven detection and localization of Breast Arterial Calcifications (BAC) in mammograms, Analysis of both full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) images, Integration with existing mammography platforms, including GE Healthcare and Hologic systems
Detection and localization of Breast Arterial Calcifications (BAC) in screening mammograms, Prioritization of mammography worklists based on AI-driven triage, Integration of BAC detection into existing mammography workflows
Radiologists, Imaging centers, Hospitals
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of CureMetrix accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence